Tandem Diabetes Care, Inc. TNDM
NASDAQ · United States · Health Technology
$16.50+0.19 (+1.16%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.31 | -0.32 | +4.4% | $254.56M | -0.2% | +14.2%$19.59→$22.38 |
| Q1 2026 | 2026-05-07 | -0.30 | -0.46 | +34.8% | — | — | -14.1%$18.03→$15.48 |
| Q4 2025 | 2026-02-19 | -0.01 | -0.09 | +88.9% | — | — | +29.7%$18.94→$24.57 |
| Q3 2025 | 2025-11-06 | -0.31 | -0.31 | 0.0% | — | — | +10.8%$14.67→$16.26 |
| Q1 2025 | 2025-04-30 | -0.67 | -0.61 | -9.8% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.44 | -0.24 | -83.3% | — | — | — |
| Q4 2023 | 2024-02-21 | -0.27 | -0.26 | -3.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.